Physician profile
Edwin Walker
NPI 1306889720
$1,117.46
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $994 · 2020: $108 · 2021: $15.27.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $288.78 | 2019-2020 | |
| Novo Nordisk INC | $250.58 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $112.98 | 2019 | |
| Scilex Pharmaceuticals INC. | $72.59 | 2019 | |
| Janssen Pharmaceuticals, INC | $69.48 | 2019 | |
| Allergan, INC. | $60.16 | 2019 | |
| Astellas Pharma US INC | $52.17 | 2019-2020 | |
| Pfizer INC. | $47.58 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.12 | 2019 | |
| Merck Sharp & Dohme LLC | $32.29 | 2019 | |
| Shire North American Group INC | $26.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $17.71 | 2019 | |
| Avanir Pharmaceuticals, INC. | $15.62 | 2019 | |
| Supernus Pharmaceuticals, INC. | $15.27 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.